Cassava Sciences- Warrants (15/11/2024)'s total liabilities is $40M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), SAVAW shows a total liabilities of $40M. That compares with $47M in the prior-year period — down 15.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SAVAW's total liabilities is now $40M (was $47M) — a 15.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cassava Sciences- Warrants (15/11/2024) is outperforming or lagging.
Tracking SAVAW's total liabilities over time shows whether Cassava Sciences- Warrants (15/11/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $40M That compares with $47M in the prior-year period — down 15.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Cassava Sciences- Warrants (15/11/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $40M) with ownership activity and broader fundamentals.
Cassava Sciences- Warrants (15/11/2024)'s total liabilities is $40M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.